Harvard Apparatus Regenerative Technology, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Harvard Apparatus Regenerative Technology, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2022-06-30 was 122.55K shares.
- Harvard Apparatus Regenerative Technology, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2022-03-31 was 917.63K shares.
- Harvard Apparatus Regenerative Technology, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2021-12-31 was 78.01K shares.
- Harvard Apparatus Regenerative Technology, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2021-09-30 was 0.00 shares, a 100.00% decline year-over-year.
- Harvard Apparatus Regenerative Technology, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2023 was 65.26K shares, a 91.58% decline from fiscal 2022.
- Harvard Apparatus Regenerative Technology, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2022 was 775.00K shares, a 893.41% increase from fiscal 2021.
- Harvard Apparatus Regenerative Technology, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2021 was 78.01K shares, a 91.62% decline from fiscal 2020.
- Harvard Apparatus Regenerative Technology, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2020 was 930.88K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2023-12-31 | 65.26K shares 10-K · filed 2025-03-31 | |
| 2022-12-31 | 775.00K shares 10-K · filed 2023-03-30 | |
| 2022-06-30 | 122.55K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | 1.12M shares derived: sum of 4 quarters · filed 2023-03-30 |
| 2022-03-31 | 917.63K shares 10-Q · filed 2022-05-16 | |
| 2021-12-31 | 78.01K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | 78.01K shares 10-K · filed 2023-03-30 |
| 2021-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | |
| 2020-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-04-13 | 930.88K shares 10-K · filed 2021-04-13 |
| 2020-09-30 | 575.32K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-13 | |
| 2020-06-30 | 141.55K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-13 | |
| 2020-03-31 | 214.00K shares 10-Q · filed 2020-05-14 |